Addex Therapeutics (ADXN) Depreciation & Amortization - Total (2024 - 2025)
Addex Therapeutics' (ADXN) quarterly Depreciation & Amortization - Total came in at $1016.3 in Q3 2025, down 8.44% quarter-over-quarter from $1110.1 in Q2 2025.
Addex Therapeutics (ADXN) Depreciation & Amortization - Total (2024 - 2025) Analysis & Trends
Addex Therapeutics has disclosed Depreciation & Amortization - Total across 2 years of filings, most recently posting $1016.3 for Q3 2025.
- Depreciation & Amortization - Total for Q3 2025 came in at $1016.3, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $1016.3 (changed N/A YoY), and the FY2025 annual result was $10218.3, down 95.35% from the prior year.
- Depreciation & Amortization - Total came in at $1016.3 for Q3 2025 at Addex Therapeutics, down from $1110.1 in the prior quarter.
- In the past five years, Depreciation & Amortization - Total ranged from a high of $1291.1 in Q4 2024 to a low of $1016.3 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Addex Therapeutics | 1.08 Bn | 1.08 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,016.34 |
| Jun 30, 2025 | 1,110.05 |
| Mar 31, 2025 | 1,138.94 |
| Dec 31, 2024 | 1,291.06 |